Literature DB >> 3292370

Prognostic factors and staging systems for multiple myeloma: comparisons between the Medical Research Council studies in the United Kingdom and the Southwest Oncology Group studies in the United States.

K A Kelly1, B Durie, I C Maclennan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3292370     DOI： 10.1002/hon.2900060213

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN： 0278-0232            Impact factor:   5.271


× No keyword cloud information.
  3 in total

Review 1.  Multiple myeloma.

Authors:  I C MacLennan; M Drayson; J Dunn
Journal:  BMJ       Date:  1994-04-16

2.  Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma.

Authors:  A Riccardi; O Mora; S Brugnatelli; C Tinelli; R Spanedda; A De Paoli; L Barbarano; M Di Stasi; C Bergonzi; M Giordano; C Delfini; G Nicoletti; E Rinaldi; L Piccinini; D Valentini; E Ascari
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

3.  Myeloma--results of treatment 1986-1990.

Authors:  P Kettle; L Ranaghan; G M Markey; J H Robertson; Z R Desai; C Bharucha; T C Morris
Journal:  Ulster Med J       Date:  1993-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.